NEJM This Week — September 4, 2025

This New England Journal of Medicine podcast episode from September 4th, 2025, covers a range of medical topics. It includes a phase 2 trial on Moritobart Cafroglutide for obesity treatment, research on stem cell-derived islets for type 1 diabetes, and a study comparing one dose versus three doses of benzathine penicillin G for early syphilis. Additionally, the podcast explores monoclonal antibodies in heparin-induced thrombocytopenia, management of acute type B aortic dissection, and a clinical problem-solving case of scurvy. Perspectives on healthcare corporatization, physician-scientist training in China, and the rise of drug innovation in China are also discussed. The episode concludes with clinical images and contact information for feedback.